Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Pancreas|July 29, 2010
The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectumLowell B Anthony, Jonathan R Strosberg, David S Klimstra, et al.Molecular Imaging and Biology|December 2, 2009
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.Advances in Radiation Oncology|July 26, 2017
18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanomaRyan S Youland, Ann T Packard, Miran J Blanchard, et al.Oncotarget|August 14, 2018
Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot studySvetomir N Markovic, Filippo Galli, Vera J Suman, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trialGregory A Wiseman, Karel Pacak, Mary S O'Dorisio, et al.Nuclear Medicine Communications|April 7, 2007
The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CTTrond V Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopeniaGregory A Wiseman, Bryan R Leigh, William D Erwin, et al.Blood|June 16, 2011
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphomaIvana N M Micallef, Matthew J Maurer, Gregory A Wiseman, et al.Expert Review of Gastroenterology & Hepatology|June 4, 2020
The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective studyMohamed A Abdallah, Nicha Wongjarupong, Mohamed A Hassan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphomaThomas E Witzig, Leo I Gordon, Fernando Cabanillas, et al.Pageof 6